Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 8 days ago Drug news

FDA approves expended indication for Stelara (ustekinumab) in moderate to severe plaque psoriasis.- Janssen Biotech.

Janssen Biotech announced that the FDA has approved an expanded indication for Stelara (ustekinumab) for the treatment of adolescents (12...

Added 10 days ago Drug news

AMAGINE-2 Phase III extension study shows two year positive results for Siliq (brodalumab injection) as a treatment of psoriasis.- Ortho Dermatologics.

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. announced results from the pivotal Phase III long-term extension study (AMAGINE-2),...

Added 18 days ago Drug news

European decentralised procedure (DCP) approval for flutiform k-haler to treat asthma. - Mundipharma.

The Mundipharma network of independent associated companies announced the positive outcome of the European Decentralised Procedure (DCP) for flutiform k-haler,...

Search all news articles for Allergy/clinical immunology
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 3 more

Visit Chronic Spontaneous Urticaria (CSU)

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

 

Guidelines

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases. 

Added 8 months ago

British Guideline on the Management of Asthma

The 2016 update includes a complete revision of the section on diagnosis of asthma and a major update to the section on pharmacological management of asthma as well as revisions to the sections on supported self management...

Added 3 years ago

Adalimumab for treating moderate to severe hidradenitis suppurativa

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Added 8 months ago

Search all guidelines for Allergy/clinical immunology
 

Journal articles

Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.

Atopic dermatitis (AD) is among the most common inflammatory skin diseases in children and adults in industrialized countries. Up to one-third of adults (probably a smaller proportion in childhood) suffer from moderate-to-severe AD...

Added 6 days ago

Dupilumab in the treatment of moderate-to-severe atopic dermatitis.

Introduction: Atopic dermatitis is a common inflammatory skin disease with an increasing prevalence. Treatment of patients suffering from mild or moderate disease includes the use of emollients and topical glucocorticoids...

Added 6 days ago

Tezepelumab in Adults with Uncontrolled Asthma.

Background: In some patients with moderate-to-severe asthma, particularly those with noneosinophilic inflammation, the disease remains uncontrolled. This trial evaluated the efficacy and safety of tezepelumab...

Added 1 month ago

Search all journal articles for Allergy/clinical immunology
 

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Added 8 months ago

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Added 8 months ago

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Added 8 months ago

Search all clinical trials for Allergy/clinical immunology
 

Blog Posts

Dr Elizabeth Angier

What’s Allergy got to do with it?

Posted 4 months ago

Experiences of an allergy and immunology congress - a short blog (by a primary care physician).

Hugh Harvey

Metrics Madness

Posted 2 years ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

Edzard Ernst

But he knows nothing about homeopathy!

Posted 2 years ago

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.

CME

Ask an expert: Psoriasis

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Management of hidradenitis suppurativa

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Allergy/clinical immunology